Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
495 News Releases found
Memorial Sloan Kettering Cancer Center Launches Innovative Projects to Improve Health in Queens and Brooklyn

Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection. With critical support from longtime MSK Board Member Bruce Ratner, the Ratner Early Detection Initiative (REDI) draws from MSK’s deep experience in cancer science and discovery, community engagement, and compassionate patient care.
MSK Awards & Appointments January 2023
MSK Awards and Appointments April 2024

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Memorial Sloan Kettering Cancer Center Issues Statement on Fiscal Year 2023 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2023 results.
An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.
Jeffrey Drebin, MD, PhD, Named President-Elect of the American Surgical Association

An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.
New Phase 1 Data from Memorial Sloan Kettering Cancer Center Shows an Investigational Cancer Vaccine May Elicit Lasting Immune Response in Patients with Pancreatic Cancer Add to Default shortcuts
New Phase 1 Data from Memorial Sloan Kettering Cancer Center Shows an Investigational Cancer Vaccine May Elicit Lasting Immune Response in Patients with Pancreatic Cancer

New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after surgery.
Memorial Sloan Kettering Cancer Center Experts to Present Leading-Edge Research at the American Association for Cancer Research Annual Meeting 2024
Memorial Sloan Kettering Cancer Center Experts to Present Leading-Edge Research at the American Association for Cancer Research Annual Meeting 2024

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.
MSK Awards & Appointments January 2023
MSK Awards & Appointments March 2024

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Prasad Adusumilli
Memorial Sloan Kettering Awarded Prestigious NCI Grant to Further Advance CAR T Cell Treatments for Solid Tumors

A team at MSK led by thoracic surgeon Dr. Prasad Adusumilli has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors.
Four Memorial Sloan Kettering Cancer Center Researchers Named 2024 Kravis Women in Science Endeavor (WiSE) Fellowship Grant Recipients
Four Memorial Sloan Kettering Cancer Center Researchers Named 2024 Kravis Women in Science Endeavor (WiSE) Fellowship Grant Recipients

Kravis WiSE promotes gender equity in science by providing stable funding and professional support for women in science at Memorial Sloan Kettering Cancer Center.
MSK Awards & Appointments January 2023
MSK Awards and Appointments February 2024

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Yael David Awarded 2024 Alfred P. Sloan Research Fel...